FAM72D, located in the 1q21.1 region of the human chromosome, has demonstrated significant potential as a prognostic biomarker in multiple myeloma [23], prostate cancer [24], kidney renal clear cell carcinoma (KIRC) [25], HCC [26], and LUAD [27]. This evidence concerns the gene FAM72D and plasma cell myeloma.